Cannabis stock news for investors : Psychedelic Stock News: Entheon Biomedical (CSE: ENBI) (OTCQB: ENTBF) Announces the Approval of DMT Clinical Trial

Psychedelic Stock News: Entheon Biomedical (CSE: ENBI) (OTCQB: ENTBF) Announces the Approval of DMT Clinical Trial

about investorideas.com

About Investorideas.com - Big Investing Ideas Investorideas.com is a platform for investing ideas. We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.

Cannabis stock news for investors

Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Thursday 3 February 2022

Psychedelic Stock News: Entheon Biomedical (CSE: ENBI) (OTCQB: ENTBF) Announces the Approval of DMT Clinical Trial

No comments:

Post a Comment

Drug Enforcement Agency (DEA) Reschedules Cannabis from Schedule I to Schedule III

about investorideas.com

Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks